Therapy of Gouty Arthritis in Obese Patients Using Cryopreserved Placental Extract


  • Tatyana N. Yurchenko Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov
  • Anna A. Kapustyanskaya Ukrainian Medical Stomatological Academy, Poltava
  • Vladimir I. Shepitko Ukrainian Medical Stomatological Academy, Poltava


gout, obesity, cryopreserved placental extract


The data about prevalence of a gout combined with obesity inUkraineare demonstrated in the research. In clinics (107 patients) we compared the outcomes of gouty arthritis therapy applying the standard protocol and the combination involving cryopreserved human placental extract (CHPE). Twelve months following treatment a positive effect of CHPE administration was revealed in the disease course: the reduction of a number and duration of arthritis attacks by 28.57%; decrease in pain index from 9.8 (prior to treatment) down to 1.4 point; content of uric acid from 768.0 down to 358.1 mmol/l; erythrocyte sedimentation rate from 35.5 down to 14.0 mm/hr; and content of C-reactive protein from 13.0 down to 4.5 mg/l. Following standard therapy these indices were, correspondingly, 14.28%; 2.8 points; 419.3 mmol/l; 18.00 mm/hr and 5.1 mg/l. Probl Cryobiol Cryomed 2013; 23(4):326–337.

Author Biography

Tatyana N. Yurchenko, Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov

Department of Cryomorphology


Barskova V.G. Diagnosis of gouty arthritis. Rus Med Zhurnal 2011; 19 (10): 614–617.

Barskova V.G. Chronic gout: reasons of development, clinical manifestations, therapy. Ther Arkh 2010; (1): 64–67.

Grischenko V.V. Estimation of application efficiency of prepa-rations of human cryopreserved fetoplacental tissues in a combined treatment of parodontitis. Vestnik of RSMU 2003; 2 (28): 158–159.

Grischenko V.I., Goltsev A.N. Transplantation of products of fetoplacental complex. From understanding of action mechanisms to improvement of application efficiency. Problems of Cryobiology 2001; (1): 54–85.

Grischenko V.I., Goncharuk O.I., Petrenko T.P. et al. Perspectives of application of cell preparations under reparative and rege-nerative processes in organism. Klinichna Khirurgiya 2006; (4–5): 87–88.

Grischenko V.I., Bobyrova L.E., Dvornik I.L. et al. Peculiarities of application of cryopreserved fetoplacental tissue in a combined therapy of Diabetes mellitus of type I. In: Proceeding of Scientific and Practical Conference ‘Actual Directions in Endocrinology Development.’ Kharkiv, 2003: 51–52.

Grischenko V.I., Goltsev A.M. Modification of state of lymphohemopoietic complex of organism under conditions of applying products of fetoplacental complex. Transplantologiya 2001; 2 (1): 32–41.

Grischenko V.I., Scherbina M.O., Tanko O.P. Introduction of novel technologies in obstetrics and gynecology. Pediatriya, Akusherstvo i Ginekologiya; (6): 110–113.

Grischenko V.I., Yurchenko T.N. Placenta: cryopreservation, structure, properties, perspectives of clinical application. Kharkov, 2011.

Goltsev A.N., Yurchenko T.N. Placenta: cryopreservation, clinical application. Kharkov, 2013.

Kondakov I.I. Anti-atherogenic effects of fetoplacental complex in reverse progress of experimental atherosclerosis. Zaporozh Med Zhurnal 2005;.(3): 122–123.

Kondakov I.I., Yurchenko T.N., Zhulikova E.P. Experimental hypercholesterinemia and lipid-correcting effect under cryopreserved placenta introduction. World of Medicine and Biology 2007; (1): 46–50.

Kutsevlyak V.F., Goltsev A.N., Ostankova L.V. et al. Study of the effect of human cryopreserved placental extract on course of experimental parodontitis in rats. Visnyk Stomatologii 2004; (1): 6–11.

Lomako I.V., Lutsenko N.S., Kirichenko I.M. Application of cryopreserved placental tissue in women with estrogen deficiency. Pediatriya, akusherstvo i ginekologiya 2000; (6): 110–113.

Nasonov E.L., Aleksandrova E.N. Current technologies and perspectives of laboratory diagnosis of rheumatoid diseases. Therapeutic Archive 2010; (5): 5–8.

Repin V.S., Sukhikh T.G. Medical cellular biology. Moscow: Bulletin of Experimental Biology and Medicine, 1998.

Sinyachenko O.V., Petrova V.M. et al. Gout as a reason and manifestation of metabolic syndrome. In: Proceeding of conference ‘Metabolic Syndrome in practice of therapist’. – Kharkiv, 2008. – P. 75–76.

Strona V.I., Stepanov A.V., Prokopyuk O.S. Plasmopheresis and implantation of placental tissue in combined therapy of atherosclerosis in patients with IHD. Meditsina Segodnya i Zavtra 1997; (2): 54–55.

Filatov V.F., Zhuravlev A.S., Prokopyuk O.S. et al. Experience of applying fetoplacental tissues in treating some ENT-diseases. In: Proceeding of Jubilee Scientific and Practical Conference, Dedicated to the 100th Anniversary of O.S. Kolomijchenko. Kyiv, 1998: 146–151.

Shepitko V.I. Structural and functional indices of cryopreserved placenta and effect of its transplantation on morphofunctional state of some internal organs. [Author’s abstract of thesis of doctor of medical sciences] Kharkiv, 2004.

Yatsychyn R.I., Migovich V.V. Peculiarities of clinical and biochemical disorders in patients with gouty arthritis at the background of metabolic syndrome and methods of their correction. Ukr Rheumatolog Journal 2010; 42 (4): 50–54.

Patent N51217. Ukraine. Way of therapy for chronic gouty arthritis aggravation. V.M. Zhadan, V.I. Shepitko, A.A. Kapustyanska. Applied 24.12.2009, published 12.07.2010– Bull. N13.

Chen W.L, Chen H.I, Loh C.H. Acute gouty arthritis after taking sildenafil: an old disease with a new etiology. J Rheumatol 2009; 36 (1): 210–211.




How to Cite

Yurchenko, T. N., Kapustyanskaya, A. A., & Shepitko, V. I. (2013). Therapy of Gouty Arthritis in Obese Patients Using Cryopreserved Placental Extract. Problems of Cryobiology and Cryomedicine, 23(4), 326–337. Retrieved from